Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-17

FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Mylan Pharmaceuticals Inc. for a fixed-dose combination of telmisartan and amlodipine. The product is intended …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Amlodipine (Telmisartan and Amlodipine)

Snippet

SUPPL AP for TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)